Immunic Inc (NASDAQ:IMUX) announced its participation in multiple September events.
The company will present at the HC Wainwright Global Investment Conference (September 8 to 10) and the Leerink Partners Biopharma Summit (September 17 to 19).
At ECTRIMS 2025 in Barcelona (September 24 to 26), Immunic will deliver an oral presentation and five posters highlighting data on vidofludimus calcium (IMU-838) in multiple sclerosis.
Presentations will be available on its website.